nelarabine 250 MG per 50 ML Injection
- RxCUI
- 603566
- RxNorm name
- nelarabine 250 MG per 50 ML Injection
- Display name
- nelarabine 250 MG per 50 ML Injection
- Full name
- nelarabine 250 MG per 50 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:30
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nelarabine | NELARABINE | Amneal Pharmaceuticals LLC | 8d0e1b59-bd1e-4c6e-9a95-e8143ee076bf | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Meitheal Pharmaceuticals Inc | 21919314-5c25-49ab-beba-099983ed4a71 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 603566 |
| nelarabine | NELARABINE | Shorla Oncology Inc. | fc401b06-4e3b-413e-a854-3e031c433862 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 603566 |
| NELARABINE | NELARABINE | Alembic Pharmaceuticals Inc. | a2a08758-9a9d-49a2-a498-9da109045ee9 | 2025-07-08 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Zydus Pharmaceuticals USA Inc. | 8cb23281-93ca-40b8-b8e0-c57dd4298322 | 2025-04-16 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Gland Pharma Limited | 651bf4d2-75b0-4a60-8014-7006ffe61084 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Zydus Pharmaceuticals USA Inc. | e425731e-626b-4141-a997-fb85e077c2a4 | 2025-04-07 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Arranon | NELARABINE | Sandoz Inc | 0f9051de-5c4d-4c0f-8c19-e15214498cca | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Arranon | NELARABINE | Novartis Pharmaceuticals Corporation | fffa5d75-0dba-4ad7-a252-5f60fa28489a | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Dr. Reddy's Laboratories, Inc. | 57275b05-f40f-7298-5a5e-93594bc41437 | 2025-03-29 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | XGen Pharmaceuticals DJB, Inc. | a1cc1580-50d9-4b9b-a002-1fc6686a9515 | 2024-12-18 | Boxed warning, Warnings, Adverse reactions | 603566 |
| NELARABINE | NELARABINE | Alembic Pharmaceuticals Limited | 03ad6056-0e71-4e7c-842a-a5f87649bdcd | 2024-08-07 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Sagent Pharmaceuticals | f60da70f-2f9e-421d-a277-95b1edb57a71 | 2024-05-28 | Boxed warning, Warnings, Adverse reactions | 603566 |
| NELARABINE | NELARABINE | Novadoz Pharmaceuticals LLC | d556a9e7-310b-41dc-99f8-a281fe7da3fe | 2023-05-16 | Boxed warning, Warnings, Adverse reactions | 603566 |
| Nelarabine | NELARABINE | Zydus Lifesciences Limited | 877b69a0-0899-455d-926e-f5a7478c31f8 | 2022-11-05 | 603566 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fffa5d75-0dba-4ad7-a252-5f60fa28489a | nelarabine 250 MG in 50 ML Injection | PSN | 10 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| fffa5d75-0dba-4ad7-a252-5f60fa28489a | 50 ML nelarabine 5 MG/ML Injection | SCD | 10 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| fffa5d75-0dba-4ad7-a252-5f60fa28489a | nelarabine 250 MG per 50 ML Injection | SY | 10 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| 8d0e1b59-bd1e-4c6e-9a95-e8143ee076bf | 50 ML nelarabine 5 MG/ML Injection | SCD | 8 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20260211 |
| 8d0e1b59-bd1e-4c6e-9a95-e8143ee076bf | nelarabine 250 MG per 50 ML Injection | SY | 8 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20260211 |
| 8d0e1b59-bd1e-4c6e-9a95-e8143ee076bf | nelarabine 250 MG in 50 ML Injection | PSN | 8 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20260211 |
| 57275b05-f40f-7298-5a5e-93594bc41437 | nelarabine 250 MG per 50 ML Injection | SY | 7 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250329 |
| 57275b05-f40f-7298-5a5e-93594bc41437 | nelarabine 250 MG in 50 ML Injection | PSN | 7 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250329 |
| 57275b05-f40f-7298-5a5e-93594bc41437 | 50 ML nelarabine 5 MG/ML Injection | SCD | 7 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250329 |
| fc401b06-4e3b-413e-a854-3e031c433862 | 50 ML nelarabine 5 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250723 |
| fc401b06-4e3b-413e-a854-3e031c433862 | nelarabine 250 MG in 50 ML Injection | PSN | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250723 |
| fc401b06-4e3b-413e-a854-3e031c433862 | nelarabine 250 MG per 50 ML Injection | SY | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250723 |
| 651bf4d2-75b0-4a60-8014-7006ffe61084 | 50 ML nelarabine 5 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250410 |
| 651bf4d2-75b0-4a60-8014-7006ffe61084 | nelarabine 250 MG per 50 ML Injection | SY | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250410 |
| 651bf4d2-75b0-4a60-8014-7006ffe61084 | nelarabine 250 MG in 50 ML Injection | PSN | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250410 |
| e425731e-626b-4141-a997-fb85e077c2a4 | nelarabine 250 MG in 50 ML Injection | PSN | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250407 |
| e425731e-626b-4141-a997-fb85e077c2a4 | nelarabine 250 MG per 50 ML Injection | SY | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250407 |
| e425731e-626b-4141-a997-fb85e077c2a4 | 50 ML nelarabine 5 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250407 |
| 8cb23281-93ca-40b8-b8e0-c57dd4298322 | nelarabine 250 MG per 50 ML Injection | SY | 5 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250416 |
| 8cb23281-93ca-40b8-b8e0-c57dd4298322 | 50 ML nelarabine 5 MG/ML Injection | SCD | 5 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250416 |
| 8cb23281-93ca-40b8-b8e0-c57dd4298322 | nelarabine 250 MG in 50 ML Injection | PSN | 5 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250416 |
| 869ac7ef-f16d-47d9-8897-29add0679dd7 | 50 ML nelarabine 5 MG/ML Injection | SCD | 5 | These highlights do not include all the information needed to use Nelarabine Injection safely and effectively. See full prescribing information for Nelarabine Injection. Nelarabine Injection, for intravenous use Initial U.S. Approval: 2005 | 20231227 |
| 869ac7ef-f16d-47d9-8897-29add0679dd7 | nelarabine 250 MG in 50 ML Injection | PSN | 5 | These highlights do not include all the information needed to use Nelarabine Injection safely and effectively. See full prescribing information for Nelarabine Injection. Nelarabine Injection, for intravenous use Initial U.S. Approval: 2005 | 20231227 |
| 869ac7ef-f16d-47d9-8897-29add0679dd7 | nelarabine 250 MG per 50 ML Injection | SY | 5 | These highlights do not include all the information needed to use Nelarabine Injection safely and effectively. See full prescribing information for Nelarabine Injection. Nelarabine Injection, for intravenous use Initial U.S. Approval: 2005 | 20231227 |
| 21919314-5c25-49ab-beba-099983ed4a71 | nelarabine 250 MG per 50 ML Injection | SY | 4 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20251001 |
| 21919314-5c25-49ab-beba-099983ed4a71 | nelarabine 250 MG in 50 ML Injection | PSN | 4 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20251001 |
| 21919314-5c25-49ab-beba-099983ed4a71 | 50 ML nelarabine 5 MG/ML Injection | SCD | 4 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20251001 |
| a2a08758-9a9d-49a2-a498-9da109045ee9 | 50 ML nelarabine 5 MG/ML Injection | SCD | 4 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250708 |
| a2a08758-9a9d-49a2-a498-9da109045ee9 | nelarabine 250 MG in 50 ML Injection | PSN | 4 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250708 |
| a2a08758-9a9d-49a2-a498-9da109045ee9 | nelarabine 250 MG per 50 ML Injection | SY | 4 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20250708 |
| 0f9051de-5c4d-4c0f-8c19-e15214498cca | 50 ML nelarabine 5 MG/ML Injection | SCD | 4 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| 0f9051de-5c4d-4c0f-8c19-e15214498cca | nelarabine 250 MG per 50 ML Injection | SY | 4 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| 0f9051de-5c4d-4c0f-8c19-e15214498cca | nelarabine 250 MG in 50 ML Injection | PSN | 4 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| a1cc1580-50d9-4b9b-a002-1fc6686a9515 | 50 ML nelarabine 5 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use. Initial U.S. Approval: 2005 | 20241218 |
| a1cc1580-50d9-4b9b-a002-1fc6686a9515 | nelarabine 250 MG per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use. Initial U.S. Approval: 2005 | 20241218 |
| a1cc1580-50d9-4b9b-a002-1fc6686a9515 | nelarabine 250 MG in 50 ML Injection | PSN | 2 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use. Initial U.S. Approval: 2005 | 20241218 |
| 03ad6056-0e71-4e7c-842a-a5f87649bdcd | nelarabine 250 MG per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20240807 |
| 03ad6056-0e71-4e7c-842a-a5f87649bdcd | 50 ML nelarabine 5 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20240807 |
| 03ad6056-0e71-4e7c-842a-a5f87649bdcd | nelarabine 250 MG in 50 ML Injection | PSN | 2 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20240807 |
| 877b69a0-0899-455d-926e-f5a7478c31f8 | nelarabine 250 MG per 50 ML Injection | SY | 2 | NELARABINE INJECTION | 20221105 |
| 877b69a0-0899-455d-926e-f5a7478c31f8 | nelarabine 250 MG in 50 ML Injection | PSN | 2 | NELARABINE INJECTION | 20221105 |
| 877b69a0-0899-455d-926e-f5a7478c31f8 | 50 ML nelarabine 5 MG/ML Injection | SCD | 2 | NELARABINE INJECTION | 20221105 |
| f60da70f-2f9e-421d-a277-95b1edb57a71 | nelarabine 250 MG in 50 ML Injection | PSN | 1 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20240528 |
| f60da70f-2f9e-421d-a277-95b1edb57a71 | 50 ML nelarabine 5 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20240528 |
| f60da70f-2f9e-421d-a277-95b1edb57a71 | nelarabine 250 MG per 50 ML Injection | SY | 1 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20240528 |
| d556a9e7-310b-41dc-99f8-a281fe7da3fe | nelarabine 250 MG in 50 ML Injection | PSN | 1 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20230516 |
| d556a9e7-310b-41dc-99f8-a281fe7da3fe | nelarabine 250 MG per 50 ML Injection | SY | 1 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20230516 |
| d556a9e7-310b-41dc-99f8-a281fe7da3fe | 50 ML nelarabine 5 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | 20230516 |